Internal Medicine, Hematology & Oncology · Lexington, KY
NPI
1770837270
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
UK Hematology/ Bmt Clinic, 800 Rose St Roach Cancer Ctr 1st Fl
Lexington, KY, 40536
Phone (859) 257-6006
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
334 services
Medicare patients, 2024
145
Average age 70
Drug cost, 2024
$2.2M
1,137 prescriptions
Company payments, 2025
$239
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chaitanya Iragavarapu was code 99233 (hospital e&m - subsequent), 100 times for 46 patients. In total Chaitanya Iragavarapu billed 334 services in 17 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 100 | 46 | $93.34 | $9,334 |
| 99214 Office E&M - Established | Facility | 69 | 49 | $68.73 | $4,742 |
| 99215 Office E&M - Established | Facility | 54 | 34 | $108.67 | $5,868 |
| 99223 Hospital E&M - Initial | Facility | 43 | 40 | $139.09 | $5,981 |
| 99205 Office E&M - New | Facility | 14 | 14 | $145.62 | $2,039 |
| 99204 Office E&M - New | Facility | 11 | 11 | $107.48 | $1,182 |
By year: 2022 $36K for 400 services; 2023 $30K for 346 services; 2024 $32K for 334 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chaitanya Iragavarapu prescribed most often to Medicare patients was Acyclovir, with 127 prescriptions and refills. In total Chaitanya Iragavarapu wrote 1,137 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 127 | 177 | 41 | $2,856 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 82 | 104 | 27 | $171 |
| Prednisone Generic | 75 | 75 | 27 | $156 |
| Prochlorperazine Maleate Generic | 73 | 73 | 33 | $933 |
| Oxycodone Hcl Generic | 72 | 72 | 23 | $909 |
| Gabapentin Generic | 61 | 77 | 16 | $460 |
| Brukinsa Zanubrutinib | 52 | 52 | Under 11 | $758K |
| Dapsone Generic | 24 | 28 | Under 11 | $1,028 |
| Promacta Eltrombopag Olamine | 23 | 23 | Under 11 | $257K |
| Pregabalin Generic | 22 | 22 | Under 11 | $439 |
| Famotidine Generic | 20 | 22 | 16 | $71.11 |
| Eliquis Apixaban | 20 | 33 | Under 11 | $20K |
| Valacyclovir Valacyclovir Hcl | 19 | 35 | Under 11 | $1,375 |
| Dexamethasone Generic | 19 | 19 | 11 | $240 |
| Enoxaparin Sodium Generic | 17 | 17 | Under 11 | $5,802 |
Brand drugs: - claims; generic drugs: 870 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chaitanya Iragavarapu $239 ($239 in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Research & Development, LLC with $146.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.